Xiangpeng Meng
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HTF4 modulates the transcription of GID2 to promote the malignant biological behavior of pancreatic cancer.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: March 01, 2024
PELI1 overexpression contributes to pancreatic cancer progression through upregulating ubiquitination-mediated INPP5J degradation.
Journal: Cellular signalling
Published: December 27, 2023
Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis.
Journal: Frontiers in oncology
Published: February 09, 2023
GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 19, 2022
PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
Journal: Cancer gene therapy
Published: August 16, 2022
Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma.
Journal: Gland surgery
Published: June 22, 2021
Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Journal: Journal of physiology and biochemistry
Published: September 26, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026